Wednesday, May 16, 2012

Vol. 18, No. 10

TRIGGER
The Twice-Monthly Electronic Newsletter on the Biology of Tissue Factor, Factor VII and TFPI
Vol. 18, No. 10  May 15, 2012
(The next issue will be on June 1, 2012)
__________________________________________________________
TRIGGER is also available by RSS Feed:
and BLOG:
http://trigger-tf7.blogspot.com/
__________________________________________________________
PAPERS IN PRESS
None submitted for this issue.
__________________________________________________________
RECENT PUBLICATIONS ON TISSUE FACTOR, FACTOR VII, AND TFPI
Papers are culled from NLM MedLine (PubMed). Titles in square brackets indicate that the paper was not published in English. References that lack volume or page numbers are typically electronic pre-publications (E-pubs) ahead of the print publication; if so, the final citation with volume and page numbers may or may not appear in a future issue of Trigger.
THE FOLLOWING LINK WILL TAKE YOU TO THE ENTIRE LIST OF THIS ISSUE'S PUBLICATIONS IN A PUBMED "COLLECTION":
http://www.ncbi.nlm.nih.gov/sites/myncbi/collections/public/1J76vYrXMqkzqh5CbndPg1i/

Andersen ND, Bhattacharya SD, Williams JB, Fosbol EL, Lockhart EL, Patel MB, . . . Hughes GC (2012) Intraoperative Use of Low-Dose Recombinant Activated Factor VII During Thoracic Aortic Operations.
Ann Thorac Surg.

Banz Y, Hess OM, Meier P, Korchagina EY, Gordeeva EA, Robson SC, . . . Rieben R (2012) Evaluation of multimeric tyrosine-O-sulfate as a cytoprotectant in an in vivo model of acute myocardial infarction in pigs. Cardiology 121:59-70.

Bouchama A, Al-Mohanna F, Assad L, Baturcam E, Eldali A, Owaidah T, Dehbi M (2012) Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon. Crit Care Med 40:1229-1236.

Bouchard BA, Krudysz-Amblo J, Butenas S (2012) Platelet tissue factor is not expressed transiently after platelet activation. Blood 119:4338-4339.

Bulato C, Radu C, Simioni P (2012) Studies on coagulation incompatibilities for xenotransplantation. Methods Mol Biol 885:71-89.

Butenas S, Amblo-Krudysz J, Mann KG (2012) Posttranslational modifications of tissue factor. Front Biosci (Elite Ed) 4:381-391.

Chuang TD, Luo X, Panda H, Chegini N (2012) miR-93/106b and Their Host Gene, MCM7, Are Differentially Expressed in Leiomyomas and Functionally Target F3 and IL-8. Mol Endocrinol.

Coates LJ, McNally J, Caputo M, Cusick E (2011) Survival in a 2-year-old boy with hemorrhage secondary to an aortoesophageal fistula. J Pediatr Surg 46:2394-2396.

Eroglu A, Ozturk A, Akar N (2011) Association between the -402GA, -401GT, and -323ins10-bp polymorphisms of factor VII gene and breast cancer. Breast Cancer 18:282-285.

Favaloro EJ, McVicker W, Zhang Y, Hamdam S, Huynh M, Peris P, . . . Hocker N (2012) Improving the inter-laboratory harmonization of the international normalized ratio (INR): utilizing the concept of transference to estimate and/or validate international sensitivity index (ISI) and mean normal prothrombin time (MNPT) values and/or to eliminate measurement bias. Clin Lab Sci 25:13-25.

Frias MA, Jaraba S, Ibarra I, Arroyo MJ, Velasco MJ, Ulloa E, . . . Perez-Navero JL (2011) Ventricular assist device as a bridge to transplant, and extracorporeal membrane oxygenation for primary graft failure in a child with hemophilia A. Pediatr Crit Care Med 12:e432-435.

Furugohri T, Fukuda T, Tsuji N, Kita A, Morishima Y, Shibano T (2012) Melagatran, a direct thrombin inhibitor, but not edoxaban, a direct factor Xa inhibitor, nor heparin aggravates tissue factor-induced hypercoagulation in rats. Eur J Pharmacol.

Govindarajan S, Sivakumar J, Garimidi P, Rangaraj N, Kumar JM, Rao NM, Gopal V (2012) Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate. Biomaterials 33:2570-2582.

Gray E, Hogwood J, Mulloy B (2012) The anticoagulant and antithrombotic mechanisms of heparin. Handb Exp Pharmacol:43-61.

Hedner U (2012) Activated factor VII: my story. Haemophilia 18:147-151.

Hedner U (2012) FVIIa as therapeutic agent in hemophilia and beyond. Front Biosci (Elite Ed) 4:1210-1223.

Hibi K, Goto T, Shirahata A, Saito M, Kigawa G, Nemoto H, Sanada Y (2012) Methylation of TFPI2 no longer detected in the serum DNA of colorectal cancer patients after curative surgery. Anticancer Res 32:787-790.

Hilden I, Lauritzen B, Sorensen BB, Clausen JT, Jespersgaard C, Krogh BO, . . . Bjorn SE (2012) Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model. Blood.

Holroyd EW, White TA, Pan S, Simari RD (2012) Tissue factor pathway inhibitor as a multifunctional mediator of vascular structure. Front Biosci (Elite Ed) 4:392-400.

Jilma B, Derhaschnig U (2012) Disseminated intravascular coagulation in heat stroke: a hot topic. Crit Care Med 40:1370-1372.

Johansson PI, Stensballe J, Rasmussen LS, Ostrowski SR (2012) High circulating adrenaline levels at admission predict increased mortality after trauma. J Trauma Acute Care Surg 72:428-436.

Kamat P, Kunde S, Vos M, Vats A, Gupta N, Heffron T, . . . Fortenberry JD (2012) Invasive intracranial pressure monitoring is a useful adjunct in the management of severe hepatic encephalopathy associated with pediatric acute liver failure. Pediatr Crit Care Med 13:e33-38.

Krysiak R, Okopien B (2011) Haemostatic effects of simvastatin in subjects with impaired glucose tolerance. Intern Med J 41:473-481.

Liu B, Zhang L, Yang Q (2012) Genetics of intracerebral hemorrhage: Insights from candidate gene approaches. Neurol India 60:3-8.

Loeffen R, Spronk HM, Ten Cate H (2012) The impact of blood coagulability on atherosclerosis and cardiovascular disease. J Thromb Haemost.

Maroney SA, Cooley BC, Ferrel JP, Bonesho CE, Nielsen LV, Johansen PB, . . . Mast AE (2012) Absence of hematopoietic tissue factor pathway inhibitor mitigates bleeding in mice with hemophilia. Proc Natl Acad Sci U S A 109:3927-3931.

Mayne E, Funderburg NT, Sieg SF, Asaad R, Kalinowska M, Rodriguez B, . . . Lederman MM (2012) Increased platelet and microparticle activation in HIV infection: upregulation of P-selectin and tissue factor expression. J Acquir Immune Defic Syndr 59:340-346.

Osterud B, Bjorklid E (2012) Tissue factor in blood cells and endothelial cells. Front Biosci (Elite Ed) 4:289-299.

Pokras SM, Petrilla AA, Weatherall J, Lee WC (2012) The economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis. Haemophilia 18:284-290.

Rao LV, Kothari H, Pendurthi UR (2012) Tissue factor: mechanisms of decryption. Front Biosci (Elite Ed) 4:1513-1527.

Reinhardt C, Bergentall M, Greiner TU, Schaffner F, Ostergren-Lunden G, Petersen LC, . . . Backhed F (2012) Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling. Nature 483:627-631.

Shibeko AM, Woodle SA, Lee TK, Ovanesov MV (2012) Unifying the mechanism of recombinant FVIIa action: dose-dependence is regulated differently by tissue factor and phospholipids. Blood.

Sorensen B, Dargaud Y, Kenet G, Lusher J, Mumford A, Pipe S, Tiede A (2012) On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII. Haemophilia 18:255-262.

Sorensen B, Fries D (2012) Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 99 Suppl 1:40-50.

Tan CW, Najm J, Morel-Kopp MC, Teo J, Chen Q, Felbor U, Ward CM (2012) Severe FX deficiency caused by a previously unidentified 4-bp deletion compound heterozygous with a large deletion involving FVII and FX genes. Haemophilia 18:e55-58.

Tan JN, Burke PA, Agarwal SK, Mantilla-Rey N, Quillen K (2012) A massive transfusion protocol incorporating a higher FFP/RBC ratio is associated with decreased use of recombinant activated factor VII in trauma patients. Am J Clin Pathol 137:566-571.

Velayudhan BT, Huderson BP, McGilliard ML, Jiang H, Ellis SE, Akers RM (2012) Effect of staged ovariectomy on measures of mammary growth and development in prepubertal dairy heifers. Animal 6:941-951.

Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, . . . Mackman N (2012) Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Blood.

Williams JC, Mackman N (2012) Tissue factor in health and disease. Front Biosci (Elite Ed) 4:358-372.

Woo HI, Park IA, Lee KO, Kim SH, Kim HJ (2012) Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes. Blood Coagul Fibrinolysis.

Yoshihiro M, Takamiya O (2012) [The expression of recombinant factor VII variants is influenced by different cells for transfection using expression studies]. Rinsho Byori 60:193-200.
http://www.ncbi.nlm.nih.gov/pubmed/22568080
__________________________________________________________
ABOUT TRIGGER
TRIGGER is edited by Jim Morrissey and Pierre Neuenschwander, with editorial assistance by Genie Morrissey. It includes Abstracts of Papers in Press, Meeting Announcements, Positions Sought/Available,or any other pertinent item that subscribers may want to share with their colleagues. To submit an item for publication in Trigger, e-mail us. To request or cancel a subscription,or for more information about TRIGGER or the biology of tissue factor and factor VII, visit our web site. You can also contact us by mail: J.H. Morrissey, University of Illinois College of Medicine, 417 Med Sci Bldg MC-714, 506 S. Mathews Ave., Urbana, IL 61801, USA.

DISCLAIMER: TRIGGER is provided "as is" for information purposes only and without warranty of any kind, express or implied. Users shall assume the entire risk as to the accuracy and usefulness of information in TRIGGER. Opinions expressed here are not necessarily those of the editors or their employers. You may share TRIGGER with your scientific colleagues but you are not permitted to use it or its contents for commercial purposes.
__________________________________________________________